Drug
[6,6-2H2] D-glucose
[6,6-2H2] D-glucose is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Terminated(1)
Detailed Status
Recruiting1
Not yet recruiting1
Withdrawn1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
recruiting125%
not_yet_recruiting125%
withdrawn125%
completed125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_1
Human Models of Selective Insulin Resistance: Alpelisib, Part I
NCT06354088
not_yet_recruitingphase_1
Human Models of Selective Insulin Resistance: Pancreatic Clamp
NCT06558422
completedphase_1
Pancreatic Clamp in NAFLD
NCT05724134
withdrawnphase_1
Dexamethasone/Pancreatic Clamp P&F
NCT06126354
Clinical Trials (4)
Showing 4 of 4 trials
NCT06354088Phase 1
Human Models of Selective Insulin Resistance: Alpelisib, Part I
NCT06558422Phase 1
Human Models of Selective Insulin Resistance: Pancreatic Clamp
NCT05724134Phase 1
Pancreatic Clamp in NAFLD
NCT06126354Phase 1
Dexamethasone/Pancreatic Clamp P&F
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4